- Nachrichtendetail
-
22.02.2024 22:06:01 - dpa-AFX: *BIOMARIN Q4 REVENUES $646.2 MLN VS. $537.5 MLN LAST YEAR
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BioMarin Pharmaceutical | 924801 | NASDAQ | 83,140 | 28.06.24 20:16:16 | -0,360 | -0,43% | 83,110 | 83,150 | 84,730 | 83,500 |
